DEF 14C

DEFINITIVE SCHEDULE 14C

Company: TherapeuticsMD, Inc.
Filed: September 4, 2009
Period of Report: September 14, 2009
Accession Number: 0001193125-09-187302

View Document ↗ View on SEC.gov ↗